MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
Aethlon Medical DPO Ratio 2011-2026 | AEMD
Annual DPO Ratio Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.8 | 42.4 | 38.3 | 33 | 32.9 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.8 | 32.9 | 41.7 |
Quarterly DPO Ratio Aethlon Medical
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.1 | 87.7 | 86.8 | - | 113 | 66.2 | 67.1 | - | 32.8 | 58.6 | 51.9 | - | 25.6 | 32.8 | 41.6 | - | 22.3 | 8.05 | 14.6 | - | 14.6 | 16.9 | 43.7 | 64 | 103 | 96.9 | 31.2 | 15.2 | 6.34 | 9.23 | 18.2 | - | 33.5 | 40.8 | 55.1 | - | 48.6 | 12.5 | 13.2 | - | 32.2 | 16.2 | 31 | - | 74.6 | 33.3 | 46 | - | 150 | 56 | 94.9 | - | 114 | 35.6 | 50.6 | - | 97.7 | 21.8 | 27.4 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 150 | 6.34 | 48.1 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
AxoGen
AXGN
|
34.4 | $ 28.6 | -1.92 % | $ 1.32 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 12.19 | -3.02 % | $ 1.83 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 36.62 | -4.9 % | $ 5.46 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 8.63 | 2.92 % | $ 620 M |  Israel |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 9.51 | -0.94 % | $ 1.29 B | USA |
 |
Electromed
ELMD
|
47.8 | $ 24.0 | -1.56 % | $ 203 M | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 40.21 | -2.9 % | $ 1.25 B | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 4.21 | -0.94 % | $ 157 M |  France |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.16 | -3.07 % | $ 109 M | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.48 | -0.48 % | $ 121 M | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 0.49 | -2.39 % | $ 50.4 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.82 | 1.35 % | $ 44.6 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 173.34 | -1.29 % | $ 13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 3.65 | -2.93 % | $ 773 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
79.7 | $ 109.92 | -0.95 % | $ 191 B | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 98.53 | -1.57 % | $ 1.25 B | USA |
 |
Inogen
INGN
|
34.6 | $ 6.46 | -1.37 % | $ 172 M | USA |
 |
InMode Ltd.
INMD
|
72.7 | $ 13.26 | -1.45 % | $ 857 M | Israel |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 71.46 | -2.09 % | $ 106 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 18.05 | 1.29 % | $ 423 M | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.24 | -10.14 % | $ 20 M | USA |
 |
Pulmonx Corporation
LUNG
|
44.6 | $ 2.03 | 25.78 % | $ 79.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.17 | -3.55 % | $ 1.32 M | USA |
 |
Medtronic PLC
MDT
|
76.2 | $ 90.96 | -2.2 % | $ 117 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 82.03 | -2.21 % | $ 48 B | USA |